#news #biotech GSK, German Merck’s $4.2B bintrafusp alfa drug flops again, but companies squint to see glimmers of hope

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GSK, German Merck’s $4.2B bintrafusp alfa drug flops again, but companies squint to see glimmers of hope .GSK, German Merck’s $4.2B bintrafusp alfa drug flops again, but companies squint to see glimmers of hope
badams
Tue, 03/16/2021 – 04:17

from FierceBiotech: Biotech https://ift.tt/3vx7bUy